Search results
Results from the WOW.Com Content Network
Pages in category "Chemical, biological, radiological and nuclear defense" The following 11 pages are in this category, out of 11 total. This list may not reflect recent changes .
The Medical CBRN (Chemical, Biological, Radiological and Nuclear) Defense Consortium, a DOD initiative within its Joint Program Executive Office for Chemical and Biological Defense has awarded the company US$20 million to develop an auto-injector to administer diazepam.
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
As a critical national asset in the CB defense community, CBC supports all phases of the acquisition life-cycle ― from basic and applied research through technology development, engineering design, equipment evaluation, product support, sustainment, field operations and demilitarization ― to address its customers’ unique requirements. [2]
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) [1] is a sub-office of the ASA(ALT).. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense is the Joint Service’s lead for development, acquisition, fielding and life-cycle support of chemical, biological, radiological and nuclear defense equipment ...
CBS News has reported on a series of financial moves the company took to issue leadership a $457 million dividend in 2018. Prospect Medical's CEO Sam Lee took home about $90 million while Leonard ...
Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida.The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. [3]
My Foolish colleague Anand Chokkavelu wrote about "8 Aerospace and Defense Stocks Near 52-Week Lows" a few months ago. These stocks are still within 25% of their 52-week lows, making them affordable.